SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is trending as a forthcoming city council vote on a massive data center project in Independence, Missouri, sparks heated community debate over economic benefits versus local concerns. Investors are also actively discussing the stock's market correlation with a competitor's recent earnings, despite many highlighting NBIS's stronger financial position within the AI infrastructure sector.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd (INDO) is trending as escalating geopolitical tensions in the Middle East, particularly concerns around the Strait of Hormuz and broader oil supply, fuel significant bullish sentiment across the energy sector. The community is actively discussing INDO's potential for a substantial rally and short squeeze, anticipating higher oil prices to persist for weeks.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil is surging due to escalating Middle East tensions driving up oil prices, fueling a massive short squeeze as the community speculates on significant upside and debates the implications of the Strait of Hormuz situation.

Hydrograph Clean Power, Inc. engages in the research, development, marketing and commercialization of patented technology to produce pristine graphene, graphene derivatives and services. The company was founded by Harold Charles Davidson on June 26, 2017 and is headquartered in Vancouver, Canada.

Hydrograph Clean Power Inc

Hydrograph Clean Power (HGRAF) is surging after securing regulatory clearances from the US EPA, UK, and EU for commercial graphene sales, removing a major bottleneck and fueling intense community discussion about its high-purity material and anticipated contracts. The recent oversubscribed capital raise further signals market confidence in its path to industrial execution and rapid expansion.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is trending following its recent full-year earnings report, which highlighted record revenue, a significant profitability turnaround, and a massive AI infrastructure pipeline, driving strong community discussion about its perceived undervaluation despite some lingering skepticism regarding past execution and stock performance.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is seeing significant investor interest following a robust Q4 earnings beat and a favorable legal outcome against Shell, while broader sentiment is fueled by surging global LNG prices due to escalating Middle East tensions impacting supply. The community is actively discussing the stock's perceived undervaluation, potential for a short squeeze, and its strong positioning to capitalize on high spot market prices.

AeroVironment, Inc. engages in the design, development, and production of multi-domain robotic systems and related services for government agencies and businesses. It operates through the following business segments: UnCrewed Systems, Loitering Munitions Systems, and MacCready Work. The UnCrewed Systems segment focuses primarily on small UAS products designed to operate reliably at lower altitudes in a wide range of environmental conditions. The Loitering Munitions Systems segment focuses primarily on tube-launched aircraft that deploy with the push of a button, fly at higher speeds than small UAS products, and perform either effects delivery or reconnaissance missions, and related support services including training, spare parts, product repair, and product replacement. The MacCready Works segment focuses on customer-funded research and development in the areas of HAPS, robotics, sensors, software analytics, data intelligence, and connectivity. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is trending after a Raymond James downgrade to Underperform, citing uncertainty around the Space Force's SCAR program, its largest contract, which triggered a sharp intraday decline. The community is actively debating whether the sell-off is an overreaction and market manipulation or a legitimate concern for the defense drone leader.

MongoDB, Inc. engages in the development and provision of a general-purpose database platform. The firm's products include MongoDB Enterprise Advanced, MongoDB Atlas, and Community Server. It also offers professional services including consulting and training. The company was founded by Eliot Horowitz, Dwight A. Merriman, Kevin P. Ryan, and Geir Magnusson Jr. in November 2007 and is headquartered in New York, NY.

MongoDB Inc - Ordinary Shares - Class A

MongoDB Inc

MongoDB is trending due to a significant after-hours sell-off following its Q4 earnings, where a beat on revenue and EPS was overshadowed by weaker-than-expected guidance and leadership departures. The community is debating if the sharp drop is an "overblown" reaction and a "buy the dip" opportunity, or if it reflects concerns over the SaaS sector's outlook and prior valuation.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as the community anticipates a Bankable Feasibility Study (BFS) update for its Tanbreez heavy rare earth project in Greenland, with discussions centered on its strategic importance for US national security and defense, amidst escalating global tensions and China's rare earth dominance.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is trending as the FDA lifted the clinical hold on its MAGNITUDE-2 Phase 3 trial, with the patient death now attributed to an ulcer rather than the CRISPR-based therapy. The community is actively discussing a significant short squeeze potential due to high short interest, with many seeing the stock as undervalued and this development as a positive signal for the broader gene-editing industry.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Black Diamond Therapeutics (BDTX) Stock Outpacing Its Medical Peers This Year?

Here is how Black Diamond (BDTX) and Bionano Genomics, Inc. (BNGO) have performed compared to their sector so far this year.

iBio, Inc. (IBIO) Reports Q1 Loss

iBio (IBIO) delivered earnings and revenue surprises of -57.14% and 0.00%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Keros Therapeutics, Inc. (KROS) Reports Q3 Loss, Tops Revenue Estimates

Keros Therapeutics (KROS) delivered earnings and revenue surprises of +83.78% and +86.04%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Exelixis (EXEL) Beats Q3 Earnings and Revenue Estimates

Exelixis (EXEL) delivered earnings and revenue surprises of +14.71% and +1.49%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Despite Fast-paced Momentum, Bionano Genomics (BNGO) Is Still a Bargain Stock

Bionano Genomics (BNGO) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Bionano Genomics (BNGO) Is Attractively Priced Despite Fast-paced Momentum

Bionano Genomics (BNGO) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Bionano Genomics triggered&nbsp;heavy retail chatter on Wednesday after the company provided a full-year 2025 revenue forecast in the range of $26 million to $30 million, falling short of the consensus estimate of $30.33 million.The company's second-quarter (Q2) revenue projection fell between $6.3 million and $6.8 million, while analysts expected $7.01 million.Bionano disclosed $6.5 million in revenue for Q1 2025, which surpassed the consensus figure of $6.25 million.&nbsp;The gross margin percentage increased to 46% compared to 32% from the previous year.&nbsp;GAAP operating expenses plunged by 66% to $11.4 million, while non-GAAP costs reduced by 65% to $8.5 million because of downsizing and restructuring product development efforts.Bionano shares closed 5.3% lower at $3.74 on Tuesday but rebounded 20.3% to $4.50 in after-hours trading.CEO Erik Holmlin noted that the March quarter represented the first period for executing their new strategy, which targets routine users of OGM systems and VIA software.&nbsp;The company reported stable utilization rates and increased consumables sales to routine users, which led to an extended cash runway until the first quarter of 2026.Bionano's Q1 sales of nanochannel array flowcells reached 6,994 units, representing a 15% decrease from the previous year, although existing customer sales expanded by 1% when accounting for new account volumes.&nbsp;The company added nine OGM systems to its network in the quarter, which increased its total system count to 379 from 347 at the same time last year.Bionano confirmed its plans to deploy between 15 and 20 new OGM systems in 2025.On Stocktwits, retail sentiment was ‘extremely bearish’ amid a&nbsp;6,300% surge in 24-hour message volume.One user warned of a potential 35% drop in the stock, while another described the company as obsolete and predicted a decline toward zero.<stembedurl>https://stocktwits.com/Jewkee/message/614685155</stembedurl><stembedurl>https://stocktwits.com/v92/message/614672774</stembedurl>The stock has declined 75.6% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Bionano Genomics (NASDAQ: BNGO) logo seen displayed on a smartphone with an Artificial intelligence (AI) chip and symbol in the background. (Photo Illustration by Budrul Chukrut/SOPA Images/LightRocket via Getty Images)

Bionano Genomics Retail Mood Turns ‘Extremely Bearish’ Amid Revenue Guidance Shortfall

Despite a 46% gross margin improvement and significant cost cuts, the stock fell over 5% on Wednesday before jumping 20% in after-hours trading

Equity

Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.

Bionano Genomics Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $MDB earnings today?

Current Price	$1.14
Prev Close	$1.15
Open	$1.10
Dividend Yield	0.00%
50-Day Moving Average	$1.39
Beta	1.67
Avg. Volume	177,221.70
PE Ratio	-0.07

52-Week High	$5.50
52-Week Low	$1.06
Market Capitalization	$11.7M
EPS (Annual)	-$88.13
Price to Book	0.22
Revenue Per Employee	$307,760.00

BNGO
Bionano Genomics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BNGO News

BNGOBionano Genomics Inc